Return On Equity of Regulus Therapeutics Inc. from 30 Jun 2013 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regulus Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2013 to 31 Mar 2025.
  • Regulus Therapeutics Inc. Return On Equity for the quarter ending 31 Mar 2025 was -58%, a 12% increase year-over-year.
  • Regulus Therapeutics Inc. annual Return On Equity for 2024 was -50%, a 54% increase from 2023.
  • Regulus Therapeutics Inc. annual Return On Equity for 2023 was -109%, a 59% decline from 2022.
  • Regulus Therapeutics Inc. annual Return On Equity for 2022 was -69%, a 8.5% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Regulus Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -58% +8% +12% 01 Jan 2025 31 Mar 2025
Q4 2024 -50% +59% +54% 01 Oct 2024 31 Dec 2024
Q3 2024 -53% +41% +44% 01 Jul 2024 30 Sep 2024
Q2 2024 -55% +30% +35% 01 Apr 2024 30 Jun 2024
Q1 2024 -66% +15% +19% 01 Jan 2024 31 Mar 2024
Q4 2023 -109% -40% -59% 01 Oct 2023 31 Dec 2023
Q3 2023 -94% -33% -53% 01 Jul 2023 30 Sep 2023
Q2 2023 -85% -18% -26% 01 Apr 2023 30 Jun 2023
Q1 2023 -81% -14% -21% 01 Jan 2023 31 Mar 2023
Q4 2022 -69% +6% +8.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -62% +12% +17% 01 Jul 2022 30 Sep 2022
Q2 2022 -68% -7% -11% 01 Apr 2022 30 Jun 2022
Q1 2022 -67% +24% +26% 01 Jan 2022 31 Mar 2022
Q4 2021 -75% +35% +32% 01 Oct 2021 31 Dec 2021
Q3 2021 -74% +77% +51% 01 Jul 2021 30 Sep 2021
Q2 2021 -61% +153% +72% 01 Apr 2021 30 Jun 2021
Q1 2021 -91% +124% +58% 01 Jan 2021 31 Mar 2021
Q4 2020 -110% +291% +73% 01 Oct 2020 31 Dec 2020
Q3 2020 -151% -1367% -112% 01 Jul 2020 30 Sep 2020
Q2 2020 -214% -2150% -111% 01 Apr 2020 30 Jun 2020
Q1 2020 -215% +163162% +100% 01 Jan 2020 31 Mar 2020
Q4 2019 -401% +270% +40% 01 Oct 2019 31 Dec 2019
Q3 2019 1216% +1528% 01 Jul 2019 30 Sep 2019
Q2 2019 1936% +2141% 01 Apr 2019 30 Jun 2019
Q1 2019 -163377% -163163% -76086% 01 Jan 2019 31 Mar 2019
Q4 2018 -671% -469% -233% 01 Oct 2018 31 Dec 2018
Q3 2018 -312% -122% -64% 01 Jul 2018 30 Sep 2018
Q2 2018 -205% -32% -19% 01 Apr 2018 30 Jun 2018
Q1 2018 -214% -88% -70% 01 Jan 2018 31 Mar 2018
Q4 2017 -202% -101% -100% 01 Oct 2017 31 Dec 2017
Q3 2017 -190% -119% -170% 01 Jul 2017 30 Sep 2017
Q2 2017 -173% -117% -209% 01 Apr 2017 30 Jun 2017
Q1 2017 -126% -75% -147% 01 Jan 2017 31 Mar 2017
Q4 2016 -101% -59% -140% 01 Oct 2016 31 Dec 2016
Q3 2016 -70% -18% -34% 01 Jul 2016 30 Sep 2016
Q2 2016 -56% -1% -0.95% 01 Apr 2016 30 Jun 2016
Q1 2016 -51% +3% +5% 01 Jan 2016 31 Mar 2016
Q4 2015 -42% +17% +29% 01 Oct 2015 31 Dec 2015
Q3 2015 -53% -10% -23% 01 Jul 2015 30 Sep 2015
Q2 2015 -56% -24% -75% 01 Apr 2015 30 Jun 2015
Q1 2015 -54% -24% -83% 01 Jan 2015 31 Mar 2015
Q4 2014 -60% -34% -134% 01 Oct 2014 31 Dec 2014
Q3 2014 -43% -7% -18% 01 Jul 2014 30 Sep 2014
Q2 2014 -32% +62% +66% 01 Apr 2014 30 Jun 2014
Q1 2014 -29% 01 Jan 2014 31 Mar 2014
Q4 2013 -25% 01 Oct 2013 31 Dec 2013
Q3 2013 -36% 01 Jul 2013 30 Sep 2013
Q2 2013 -93% 01 Apr 2013 30 Jun 2013

Regulus Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -50% +59% +54% 01 Jan 2024 31 Dec 2024
2023 -109% -40% -59% 01 Jan 2023 31 Dec 2023
2022 -69% +6% +8.5% 01 Jan 2022 31 Dec 2022
2021 -75% +35% +32% 01 Jan 2021 31 Dec 2021
2020 -110% +291% +73% 01 Jan 2020 31 Dec 2020
2019 -401% +270% +40% 01 Jan 2019 31 Dec 2019
2018 -671% -469% -233% 01 Jan 2018 31 Dec 2018
2017 -202% -101% -100% 01 Jan 2017 31 Dec 2017
2016 -101% -59% -140% 01 Jan 2016 31 Dec 2016
2015 -42% +17% +29% 01 Jan 2015 31 Dec 2015
2014 -60% -34% -134% 01 Jan 2014 31 Dec 2014
2013 -25% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.